Publikationen, an denen er mitarbeitet Manuel de-Miguel (29)

2020

  1. Mitochondrial imbalance as a new approach to the study of fibromyalgia

    Open Access Rheumatology: Research and Reviews, Vol. 12, pp. 175-185

2017

  1. Amitriptyline down-regulates coenzyme Q10biosynthesis in lung cancer cells

    European Journal of Pharmacology, Vol. 797, pp. 75-82

2016

  1. Amitriptyline induces mitophagy that precedes apoptosis in human HepG2 cells

    Genes and Cancer, Vol. 7, Núm. 7-8, pp. 260-277

  2. Targeted multifunctional tannic acid nanoparticles

    RSC Advances, Vol. 6, Núm. 9, pp. 7279-7287

2014

  1. Clinical symptoms in fibromyalgia are associated to overweight and lipid profile

    Rheumatology International, Vol. 34, Núm. 3, pp. 419-422

  2. Coenzyme Q10 therapy

    Molecular Syndromology, Vol. 5, Núm. 3-4, pp. 187-197

  3. NLRP3 inflammasome is activated in fibromyalgia: The effect of coenzyme Q10

    Antioxidants and Redox Signaling, Vol. 20, Núm. 8, pp. 1169-1180

  4. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder

    Brain, Behavior, and Immunity, Vol. 36, pp. 111-117